{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:26:23Z","timestamp":1761765983492},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhujiang Technology New Star Foundation of Guangzhou","award":["2012J2200086"],"award-info":[{"award-number":["2012J2200086"]}]},{"name":"Guangdong Provincial Natural Science Fund","award":["2014A030313462"],"award-info":[{"award-number":["2014A030313462"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vaccine.2015.12.039","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T16:06:53Z","timestamp":1450886813000},"page":"622-629","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ni","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.039_bib0230","series-title":"H5N1 highly pathogenic avian influenza: timeline of major events","author":"WHO","year":"2014"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tim.2011.10.003","article-title":"The changing nature of avian influenza A virus (H5N1)","volume":"20","author":"Watanabe","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0240","series-title":"Evolution of the influenza A (H5) haemagglutinin: WHO\/OIE\/FAO H5 working group reports a new clade designated 2.3.4.4","author":"WHO","year":"2015"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13567-014-0127-2","article-title":"Novel H5 clade 2.3.4.6 viruses with both \u03b1-2, 3 and \u03b1-2, 6 receptor binding properties may pose a pandemic threat","volume":"45","author":"Li","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0250","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.vetmic.2014.11.030","article-title":"Novel reassortant H5N5 viruses bind to a human-type receptor as a factor in pandemic risk","volume":"175","author":"Li","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0255","series-title":"WHO China statement on H5N6","author":"WHO","year":"2014"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.20506\/rst.28.1.1860","article-title":"Avian influenza vaccination: the experience in China","volume":"28","author":"Chen","year":"2009","journal-title":"Rev Sci Tech (Int Off Epizoot)"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0265","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0270","first-page":"11","article-title":"Current situation of avian influenza and its influence on the poultry industry","volume":"17","author":"Liao","year":"2014","journal-title":"Vet Orientation"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0275","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/JVI.65.10.5491-5498.1991","article-title":"Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins","volume":"65","author":"Ito","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0285","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0290","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0300","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0305","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2. 4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0310","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-M2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0315","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2015.03.096","article-title":"Advances and challenges in mucosal adjuvant technology","volume":"33","author":"Newsted","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0320","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0264-410X(98)00076-0","article-title":"Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen","volume":"16","author":"Verweij","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0325","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1128\/IAI.69.5.3476-3482.2001","article-title":"Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its closely related homologue, the B subunit of cholera toxin","volume":"69","author":"Millar","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0330","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.vaccine.2005.12.054","article-title":"Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin","volume":"24","author":"Yamanaka","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2013.02.010","article-title":"Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant","volume":"164","author":"Sun","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0340","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nbt1095","article-title":"Baculovirus as versatile vectors for protein expression in insect and mammalian cells","volume":"23","author":"Kost","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0345","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.biotechadv.2011.04.004","article-title":"Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications","volume":"29","author":"Chen","year":"2011","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0350","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jbiotec.2006.07.012","article-title":"Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes","volume":"127","author":"Yin","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0355","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2013.03.067","article-title":"Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity","volume":"31","author":"Quattrocchi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0360","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.178.4.2361","article-title":"Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN","volume":"178","author":"Hervas-Stubbs","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0365","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0370","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2013.12.006","article-title":"BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0375","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.01812-10","article-title":"T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model","volume":"85","author":"Guo","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0380","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3201\/eid2105.141927","article-title":"Rapid emergence of highly pathogenic avian influenza subtypes from a subtype H5N1 hemagglutinin variant","volume":"21","author":"Vries","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0385","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.4049\/jimmunol.163.12.6502","article-title":"MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants","volume":"163","author":"Simmons","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0390","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1016\/j.vaccine.2009.06.053","article-title":"Effective CD8+ T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells","volume":"27","author":"Fu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0395","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","article-title":"Non-toxic derivatives of LT as potent adjuvants","volume":"29","author":"Da Hora","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0400","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"Abe","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0405","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/JVI.79.5.2847-2858.2005","article-title":"Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus","volume":"79","author":"Abe","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0410","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0415","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0420","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nano.2013.08.005","article-title":"Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines","volume":"10","author":"Wang","year":"2014","journal-title":"Nanomed: Nanotechnol Biol Med"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0425","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0430","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0435","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0440","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.160.3.814","article-title":"In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific","volume":"160","author":"Lukacher","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0445","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1743-422X-10-104","article-title":"Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice","volume":"10","author":"Kim","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.12.039_bib0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetmic.2014.01.001","article-title":"Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection","volume":"169","author":"Park","year":"2014","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T10:13:34Z","timestamp":1718273614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15018368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0264410X15018368"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}